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OBJECTIVES The study investigated the relation of age with diabetes, obesity and hypertension on left
ventricular mass (LVM).
BACKGROUND Epidemiological studies demonstrate a general rise of LVM with aging, but whether this
phenomenon is independent or a function of coexisting diseases that accompany the aging
process is unclear. Although obesity, hypertension and diabetes often coexist and increase in
prevalence with age, studies of LVM in diabetics have been reported in mostly nonobese
populations, and with little regard to the age-hypertension-obesity interactions and effects on
LVM.
METHODS We prospectively measured LVM in 875 consecutive, mostly obese individuals (673 men, 202
women). Clinical data were obtained by chart review and clinical history. Echocardiographic
measurements of LVM (American Society of Echocardiography criteria) were calculated
using the Devereux formula and corrected for height2.7 (LVM/Ht).
RESULTS Mean age was 49.3 6 12.3 years, body mass index 33.3 6 8.0 kg/m2, and LVM/Ht2.7 41.7 6
13.4 g/m2.7. Of the total cohort, 673 patients were men, 519 obese, 228 hypertensive, and 52
diabetic. Of the 519 obese, 183 were hypertensive and 44 were diabetic (22 of those were
hypertensive). Of the 228 hypertensives, 183 were obese and 26 were diabetic. On
multivariate analysis, obesity (p 5 0.0001), age (p 5 0.0001), hypertension (p 5 0.0003) and
diabetes (p 5 0.02) were all independently associated with LVM/Ht2.7. Obesity was the most
potent independent predictor of LVM/Ht2.7, associated with an increase of 8.1 g/m2.7 in
LVM/Ht2.7. In diabetics, obesity had a synergistic effect on LVM/Ht2.7 (p 5 0.006), which
was further amplified by age (p 5 0.03).
CONCLUSIONS Age, obesity, hypertension and diabetes are all independent determinants of LVM. The
magnitude of the effect of diabetes on LVM is mainly consequent to a significant interaction
of diabetes with obesity and age. (J Am Coll Cardiol 2001;37:1957–62) © 2001 by the
American College of Cardiology
Left ventricular mass (LVM) is a strong predictor of
cardiovascular morbidity and mortality (1). Epidemiological
studies demonstrate a general rise in LVM with advancing
age, but whether this phenomenon is independent (i.e., part
and parcel of the aging process) or a function of coexisting
disease states that accompany the aging process is not clear
(2–7). Obesity and hypertension, two major determinants of
LVM, tend to increase with age and, when combined, are
characterized by a high prevalence of diabetes (8), which in
itself has been independently linked to left ventricular
hypertrophy (LVH) (9). Pathological and echocardio-
graphic studies of LVM in diabetics, who tend to be older,
obese and often hypertensive (10), to date have been
reported in mostly nonobese populations (11–13), with little
attention to the potential age-hypertension-obesity interac-
tions and effects on LVM.
Because some of these factors are modifiable and poten-
tially influence morbidity and mortality, we planned this
study to evaluate the contribution of these factors and their
potential interactions on LVM in a large cohort of mostly
obese patients with a wide age range, high prevalence of
hypertension and a substantial number of diabetics. We
hypothesized that there is a significant interaction among
these factors, and specifically, that the effects of diabetes on
LVM may be related to aging and to the presence of
hypertension and obesity.
METHODS
The study population consisted of 953 consecutive patients
from the metropolitan Toronto area referred for echocardi-
ography as part of cardiopulmonary investigation for further
evaluation of dyspnea and fatigue. From this total, 875
(91.2%) patients, 673 men and 202 women, aged 49.3 6
12.3 years, mean body mass index (BMI) 33.3 6 8.0 kg/m2,
had satisfactory echocardiographic images and were in-
cluded in the study.
Diabetes was defined according to the American Diabetes
Association guidelines at the time of the study (fasting
glucose of .7.8 mmol/liter) and treated by the primary care
physician. No data are available regarding the degree of
glycemic control.
Hypertension was defined and treated by the primary care
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physician in accordance with the Fifth Joint National
Committee (resting blood pressure .160/90), the accepted
guidelines at the time of the study. Coronary artery disease
(CAD) was defined clinically by a known history of angina
or myocardial infarction and by chart review. In addition,
weight and height were measured, and BMI calculated in
every patient. As widely accepted, patients with BMI .30
kg/m2 were classified as obese (14,15).
Echocardiographic methods. Echocardiographic studies
were performed at rest with the patient at steady state in the
left lateral position, using commercially available Hewlett-
Packard 1000 or newer systems with 2.5-MHz transducers
and reviewed by two experienced readers. Two-dimensional
guided M-mode measurements of left ventricular end dia-
stolic dimension (LVEDD), interventricular septal thick-
ness and posterior wall (PW) thickness were measured at
the left ventricular (LV) minor axis at the level of the
chordae tendinae just beyond the mitral leaflet tips, as
recommended by the American Society of Echocardiogra-
phy (ASE) (16). Every effort was made to obtain optimal
echocardiographic images, with the M-mode cursor perpen-
dicular to the LV long axis.
The LVM was calculated using measurements of
LVEDD, interventricular septum (IVS) and PW thickness,
made according to the standard ASE leading-edge-to-
leading-edge methodology, at the onset of the QRS com-
plex on a simultaneously acquired electrocardiogram. The
LVM was calculated using the corrected ASE formula
described by Devereux et al. (17): LVM (g) 5 0.80 [1.04 3
(LVEDD 1 IVS 1 PW)3 2 LVDD3] 1 0.6. The LVM
was corrected for height2.7 (LVM/m2.7) by dividing it by
height2.7 as previously reported (18) and expressed in units
of grams per meter2.7 (g/m2.7). Thus, LVH was defined as
LVM/Ht2.7 .47 g/m2.7 for women and .50 g/m2.7 for
men (18). Echocardiographic parameters were measured by
consensus by two experienced observers, blinded to the
clinical and metabolic data. Interobserver variability of
LVM assessment in the obese population in our laboratory
has been previously published (19).
Statistical analysis. All values for quantitative measures are
expressed as the mean 6 1 SD. Categorical variables are
presented as percent. Comparisons across groups were
performed by using the two-tailed Student t test when
comparing continuous variables and chi-square test when
comparing categorical variables.
The contribution of the different risk factors (including
gender, age, BMI, CAD, hypertension and diabetes) to the
LVM/Ht2.7 was determined by a multivariate linear regres-
sion. Only the interaction terms that were statistically
significant were retained in the final models. Plots were
made to show the predicted LVM/Ht2.7 for varying BMI
and age and interactions with diabetes. Additional models,
evaluating the contribution of the different predictors on
LVM in men and women separately as well as excluding the
patients with CAD, were also calculated. All statistical
significance was assessed at the 0.05 level. Statistical analysis
was performed utilizing the SAS statistical package, version
6.12 (SAS Institute, Cary, North Carolina).
RESULTS
The average age of the study population was 49.3 6 12.3
years, BMI 33.3 6 8.0 kg/m2 and LVM/Ht2.7 (41.7 6 13.4
g/m2.7. Of the 875 patients, 673 (77%) were men, 519
(59.3%) were obese, 228 (26%) were hypertensive, and 52
(6.0%) were diabetic. Of the 519 obese patients, 183
(35.3%) were hypertensive and 44 (8.5%) were diabetic (22
of those were hypertensive). Of the 228 hypertensives, 183
(82.6%) were obese and 26 (11.4%) were diabetic (22 of
those were obese). One hundred and thirty (57%) of the
hypertensive patients were on antihypertensive therapy, and
the remaining 98 were managed with diet and lifestyle
modification. Fifty-two patients (31 men) were diabetic, 26
of which (50%) were hypertensive (22 of those were obese).
Twenty-seven (51.9%) of the diabetics were on hypoglyce-
mic medications and 25 were diet controlled.
Baseline characteristics of the overall study population
and according to the presence of obesity are described in
Table 1.
Results of the multivariate linear regression analysis are
summarized in Table 2. Several predictors demonstrated an
independent and additive effect on LVM. Obesity was
found to be the strongest correlate of LVM/Ht2.7 followed
by CAD, hypertension, and age.
Multivariate predictors of LVM/Ht2.7. GENDER. There
were no significant gender-based differences in LVM/Ht2.7
(p 5 0.9).
CAD. This was an independent predictor of LVM/Ht2.7
(p 5 0.02), associated with an increase of 4.1 g/m2.7 in
LVM/Ht2.7.
HYPERTENSION. Hypertension was an independent predic-
tor of LVM/Ht2.7, associated with an increase of 3.6 g/m2.7
on LVM/Ht2.7.
OBESITY. Obesity was the most potent independent predic-
tor of LVM/Ht2.7 (p 5 0.0001), associated with an increase
of 8.1 g/m2.7 in LVM/Ht2.7. When using BMI as a
continuous variable, every 4 kg/m2 increase in BMI was
associated with a 2.94 g/m2.7 increase in LVM/Ht2.7.
Abbreviations and Acronyms
ASE 5 American Society of Echocardiography
BMI 5 body mass index
CAD 5 coronary artery disease
DM 5 diabetes mellitus
IVS 5 interventricular septum
LVEDD 5 left ventricular end diastolic dimension
LVH 5 left ventricular hypertrophy
LVM 5 left ventricular mass
LVM/Ht2.7 5 left ventricular mass corrected for height2.7
PW 5 posterior wall
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AGE. Age was a significant predictor of LVM/Ht2.7 (p 5
0.0001), associated with a 1.4 g/m2.7 increase in LVM/Ht2.7
for every 10-year increase in age.
DIABETES. Diabetes was a significant predictor of LVM/
Ht2.7 (p 5 0.02), with its major impact expressed through
significant interactions with age and obesity. For example,
in a 49-year-old patient with BMI of 33 kg/m2 (mean age
and BMI in our study population), diabetes is associated
with an increase of 0.24 g/m2.7 in LVM/Ht2.7, whereas in a
patient with the same age, but with a BMI of 40 kg/m2,
diabetes is associated with an increase of 3.49 g/m2.7 in
LVM/Ht2.7.
Interaction among age, diabetes, and obesity on LVM.
The effect of the age and obesity on LVM/Ht2.7 in the study
population is shown in Table 2. A strong interaction existed
between obesity and diabetes on LVM/Ht2.7 (p 5 0.006),
which was further amplified by the age (p 5 0.03), as seen
in Figure 1.
When analyzing men and women separately, the effect of
age and obesity as strong independent predictors of LVM/
Ht2.7 was again demonstrated, but their interaction with
diabetes appeared to be more gender based. As all diabetic
women in this study were obese, an interaction between
BMI (as a continuous measure of severity of obesity) and
diabetes was evaluated in this subgroup. In women, a
significant interaction between BMI and diabetes on LVM/
Ht2.7 (p 5 0.003) was present and was amplified by age
(p 5 0.005). In men, a strong interaction between diabetes
and obesity was again demonstrated (p 5 0.0001), but not
with age. We found no further significant interactions
between the other analyzed variables on LVM.
Model excluding patients with CAD. Excluding all the
patients with CAD from the analysis did not significantly
modify the results. Hypertension (p 5 0.0003), obesity (p 5
0.0001) and age (p 5 0.0001) were all significant determinants
of LVM/Ht2.7 with a persistent significant interaction between
diabetes and obesity on LVM/Ht2.7 (Table 3, Fig. 2).
DISCUSSION
In this study we analyzed the impact of age, obesity,
hypertension, CAD, and diabetes mellitus (DM) on LVM
in a large cohort of a mainly obese patient population.
Obesity was the strongest predictor of LVM in this popu-
lation, and its effects on LVM were additional to the clear
and independent effects of age, CAD, and hypertension.
Diabetes is an independent predictor of LVM, but its effects
are magnified through significant interactions with obesity
and increasing age.
The present study results differ in several respects from
previous studies that have shown the association between
LVM and DM, the most important of which is the
inclusion of a large number of obese and hypertensive
subjects, allowing an analysis of the effects of DM on LVM
in relation to these most common associated factors. The
results indicate that in addition to the independent effects of
obesity, hypertension, age, CAD, and DM on LVM/Ht2.7,
the increased LVM found in diabetics is mainly consequent
to the interaction of diabetes with obesity, which is ampli-
fied by the aging process.
Table 1. Clinical Characteristics of the Study Population
Obese
(n 5 519)
Nonobese
(n 5 356)
p
Value
All
(n 5 875)
Age (yrs) 49.5 6 12.4 48.9 6 12.1 0.4* 49.3 6 12.3
Men 383 (73.8%) 290 (81.5%) 0.008† 673 (77%)
BMI (kg/m2) 38.1 6 6.9 26.3 6 2.6 0.0001* 33.3 6 8.0
Hypertension 183 (35.3%) 45 (12.6%) 0.001† 228 (26%)
CAD 46 (8.9%) 11 (3.1%) 0.001† 57 (6.5%)
Diabetes 44 (8.5%) 8 (2.3%) 0.001† 52 (6%)
LVM/Ht2.7 (g/m2.7) 45.9 6 14.3 35.2 6 8.3 0.0001* 41.7 6 13.4
*Two-sample t test. †Chi-square test.
BMI 5 body mass index; CAD 5 coronary artery disease; LVM/Ht2.7 5 left ventricular mass corrected for height2.7.
Table 2. Multiple Linear Regression Analysis: Determinants of
LVM/Ht2.7 (n 5 875)
Estimate SE 95% CI p Value
Intercept 28.2 13.8 26.1, 30.4 0.0001
Obesity 8.1 0.87 7.2, 9.0 0.0001
Gender 20.1 0.97 21.1, 0.9 0.9
Age 0.14 0.03 0.11, 0.18 0.0001
HTN 3.6 0.99 2.6, 4.7 0.0003
CAD 4.1 1.7 2.3, 5.9 0.02
Diabetes 220.6 9.2 230.4, 210.9 0.02
Age-DM* 0.31 0.14 0.16, 0.46 0.03
DM-Obesity* 12.9 4.7 7.9, 17.9 0.006
*Interaction.
CAD 5 coronary artery disease; CI 5 confidence interval; DM 5 diabetes
mellitus; HTN 5 hypertension; LVM/Ht2.7 5 left ventricular mass corrected for
height2.7; SE 5 standard error.
Table 3. Multiple Linear Regression Analysis: Determinants of
LVM/Ht2.7 excluding CAD (n 5 818)
Estimate SE 95% CI p Value
Intercept 27.3 1.8 25.4, 29.2 0.0001
Obesity 8.2 0.9 7.3, 9.1 0.0001
Age 0.16 0.03 0.12, 0.20 0.0001
Hypertension 3.7 1.01 2.6, 4.8 0.0003
DM-Obesity* 8.4 2.1 6.2, 10.6 0.0001
*Interaction.
CAD 5 coronary artery disease; CI 5 confidence interval; DM 5 diabetes
mellitus; LVM/Ht2.7 5 left ventricular mass corrected for height2.7; SE 5 standard
error.
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Obesity, hypertension and LV mass. The prevalence of
hypertension in North America varies from 4% in the 18 to
24-year-old group to as high as 60% in the 65 to 74-year-
old group (2). Obesity, a condition that affects one-third of
the North American population (20), magnifies the risk of
hypertension by a factor of 1.9 to 5.6 and much more so in
patients with android or central body obesity (21).
In the Framingham Heart Study, obesity was an inde-
pendent predictor of echocardiographic LVH (2), with a
51% increase in the risk of LVH in women and a 47%
increase in men for every 2 kg/m2 increment in BMI. More
important was the additive effect of obesity and hyperten-
sion, which resulted in a 17-fold increase in LVH from the
group with low pressure and normal weight to the group
with higher pressure and highest BMI. Our study supports
these findings, with an overall prevalence of LVH of 23.5%,
which is dependent on BMI and hypertension, ranging
from 3.6% in the healthy lean individuals to 54.5% in
diabetic obese hypertensives (Fig. 3).
Pathological examination of the gross and microscopic
anatomy of hearts of patients with marked chronic obesity
showed the heart weight to be considerably greater than
predicted by extrapolation from ideal body weight, with LV
dilation and hypertrophy and occasionally right ventricular
hypertrophy (22). This increase was due mostly to myocar-
dial hypertrophy, occasionally associated with myocardial
Figure 1. Interaction of age with diabetes on left ventricular mass corrected for height2.7 (LVM/Ht2.7) in the presence of obesity (n 5 875).
Figure 2. Interaction of obesity with diabetes on left ventricular mass corrected for height2.7 (LVM/Ht2.7), excluding coronary artery disease patients (n 5
818).
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fibrosis, and not to excess epicardial fat or fatty infiltration
of the myocardium, previously thought to be principal
features of the obese heart (23).
Diabetes, hypertension and LVM. The overall prevalence
of DM in the North American adult population is 6.6%,
most of whom are obese (10,24), and hypertension is twice
as frequent in people with diabetes as it is in those without
(25). An association between diabetes and LVM was
previously reported by Galderisi et al. (9), but no further
data on BMI, the prevalence or severity of obesity in the
diabetic population, were presented.
The association of DM and hypertension with LVH had
been previously studied, but not in relation to obesity.
Grossman et al. (12) studied 25 diabetic hypertensives and
found that septal and PW thickness and consequently
LVMI (LVM indexed to body surface area) were increased
in diabetic hypertensives in comparison to matched nondi-
abetic hypertensives and to normal controls. Average age
was 59 6 10 years, but the mean BMI of 28.7 6 5.5 kg/m2
among the diabetic hypertensives was much lower than in
our study (40.2 6 9.4 kg/m2), and the prevalence of obesity
was not reported.
In a study by Van Hoeven and Factor (11) of patients
who died from congestive heart failure, the cardiac patho-
logic features found at autopsy in diabetics were compared
to those seen in patients with either diabetes with hyper-
tension or hypertension alone. Patients with both diabetes
and hypertension were found to have greater LV wall
thickness and the heaviest hearts, suggesting additive effects
or possibly an interaction. Body mass index was not de-
scribed, and the impact of obesity on LVM in these patients
was not assessed. Our results further extend these previous
findings by demonstrating the role of obesity as an amplifier
of the effects of DM on LVM.
Age and LVM. Previous studies have reported discrepant
findings on the relation between age and LVM. Although
the effects are modest, our findings support those of Levy et
al. (2) and Koren et al. (3), who described a progressive
increase in LVM with increasing age, which was indepen-
dent of BMI and hypertension.
Additionally, our results confirm the findings by Gal-
derisi et al. (9) of an interaction between age and diabetes on
LVM in women, but importantly we relate it to the
coexistence of obesity. The reason for the significant effects
of age on LVM in obese diabetic women is still unknown,
but is consistent with previous findings of a higher cardio-
vascular morbidity and mortality in this population (26,27).
Study limitations. This cross-sectional study is limited by
design to observational differences between groups. More
than 90% of the patients studied were Caucasians, and our
findings cannot be extrapolated to African-Americans, a
population with a high prevalence of obesity-diabetes-
hypertension. Additionally, this was a referred population
with dyspnea and fatigue, and although a selection bias
cannot be excluded, the large number of patients included in
the study—all with normal LV function—and the high
prevalence of dyspnea and fatigue of undefined etiology
among the general obese population lend further validity to
these findings. Effect of severity of hypertension and phar-
macologic therapy on LV mass in the various subgroups
could not be measured, as these data were not available. In
addition, as 87% of the hypertensive women were obese and
as obesity is a more potent predictor of LVM, the modest
effects of hypertension on LVM were relatively minimized
by the effects of obesity, rendering them statistically insig-
nificant in this subgroup.
Finally, the prevalence of diabetes in this study was very
low, even among the obese. Although not well evaluated,
Figure 3. Prevalence of left ventricular hypertrophy (LVH) according to obesity, hypertension, and diabetes (n 5 875).
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this is likely explained by a lower prevalence in our popu-
lation of some of the correlates of DM in the obese,
including duration and severity of obesity (28,29), distribu-
tion of obesity (30), family history (31), ethnic background
(32) and older age (33).
CONCLUSIONS
Our results confirm the independent association of age,
CAD, hypertension, obesity, and DM with LVM. Obesity,
a preventable disorder and a current epidemic, is the
strongest determinant of LVM, and its effects on LVM are
additive to those of age, hypertension, and diabetes.
The magnitude of the effects of diabetes on LVM is
mainly consequent to the interaction of diabetes with
obesity and aging. As diabetic subjects are usually older and
obese, these interactions explain most of the increase in
LVM in this population.
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